TGA Approval

RIVASTIGMINE-DRLA rivastigmine (as hydrogen tartrate) 3 mg capsule blister pack (177398)

ARTG ID

177398

ARTG Name

RIVASTIGMINE-DRLA rivastigmine (as hydrogen tartrate) 3 mg capsule blister pack

Sponsor

Dr Reddys Laboratories Australia Pty Ltd

ARTG Date

September 24, 2012

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

DR REDDY'S LABORATORIES (AUSTRALIA) PTY LTD

Ingredient Name

rivastigmine hydrogen tartrate

Empowering clinical research with data-driven insights and AI-powered tools.

RIVASTIGMINE-DRLA rivastigmine (as hydrogen tartrate) 3 mg capsule blister pack (177398) - TGA 批准文号 | MedPath